Pharmacodynamics

Correct Answer

B — Haloperidol

Rationale

Haloperidol is a first-generation antipsychotic classified as a QT interval-prolonging agent. Like other drugs in this category — including methadone, sotalol, amiodarone, macrolide antibiotics, fluoroquinolones, and azole antifungals — haloperidol blocks cardiac potassium channels responsible for ventricular repolarization, prolonging the QT interval and increasing the risk of torsades de pointes, a potentially fatal polymorphic ventricular tachycardia. Metoprolol is a beta-1 selective adrenergic antagonist that does not prolong QT and is sometimes used to manage arrhythmias. Lisinopril is an angiotensin converting enzyme inhibitor with no significant QT effect. Amlodipine is a calcium channel blocker used for hypertension and angina that does not prolong cardiac repolarization.

Correct Answer

D — Aminoglycosides

Rationale

Aminoglycosides (gentamicin, tobramycin, amikacin) have a narrow therapeutic index and cause direct proximal tubule toxicity through intracellular drug accumulation, making nephrotoxicity a major dose-limiting concern requiring therapeutic drug monitoring. Their combination with vancomycin produces synergistic nephrotoxicity substantially greater than either agent alone. Penicillins and cephalosporins have therapeutic indices in the hundreds and cannot realistically be dosed to toxicity in clinical use. Macrolides are associated with QT prolongation and gastrointestinal adverse effects rather than direct nephrotoxicity, and they do not require plasma concentration monitoring for nephrotoxicity prevention.

Correct Answer

A — Vancomycin

Rationale

Vancomycin independently causes tubular injury through mechanisms that include oxidative stress in proximal tubule cells. When combined with aminoglycosides — which also cause direct proximal tubule toxicity — the result is synergistic nephrotoxicity that is substantially greater than the sum of either agent's individual renal toxicity. This well-documented interaction requires daily serum creatinine monitoring and, when possible, avoidance of the combination in favor of equally effective but less nephrotoxic alternatives. Azithromycin is a macrolide antibiotic whose primary concern is QT prolongation, not nephrotoxicity. Doxycycline and clindamycin do not have significant nephrotoxic profiles and do not interact with aminoglycosides to produce additive kidney injury.

Correct Answer

C — Gabapentin

Rationale

Gabapentin and its analog pregabalin reduce excitatory neurotransmitter release through calcium channel modulation in the brainstem and spinal cord. When combined with opioids, they add to respiratory depression through a pharmacodynamic interaction at the brainstem respiratory control centers, and the combination has been associated with increased overdose mortality in population-level studies. This interaction cannot be predicted or prevented by monitoring plasma concentrations of either drug alone — it is a pharmacodynamic convergence. Acetaminophen is analgesic through central and peripheral mechanisms that do not meaningfully add to opioid respiratory depression. Celecoxib and naproxen are anti-inflammatory agents whose primary risks with opioids are gastrointestinal and renal, not respiratory.

Correct Answer

B — Warfarin

Rationale

Warfarin inhibits vitamin K epoxide reductase complex 1, the enzyme that recycles vitamin K to its active form needed for clotting factor synthesis. A promoter polymorphism in the gene encoding this enzyme alters how much enzyme is expressed: patients carrying the variant allele produce less target enzyme and therefore achieve the same anticoagulant effect at a much lower warfarin dose. This is pharmacodynamic variability — the same plasma concentration produces different effects depending on target enzyme genotype. Apixaban, rivaroxaban, and dabigatran are direct oral anticoagulants that inhibit factor Xa or thrombin directly; they do not act on vitamin K epoxide reductase complex 1 and do not exhibit the same pharmacodynamic genetic variability, which is one reason they have more predictable dose-response relationships without routine monitoring.

Correct Answer

D — Metoprolol

Rationale

Metoprolol is the beta-1 selective agent for which the clinical relevance of beta-1 adrenergic receptor gene polymorphisms has been most extensively studied, particularly in the context of heart failure. Patients carrying the more active receptor variant achieve greater hemodynamic responses and better heart failure outcomes with metoprolol than those with the less active variant. This variability is pharmacodynamic — it reflects differences in receptor sensitivity at a given drug concentration, not differences in drug metabolism or plasma levels. Propranolol is non-selective and has been less studied for this specific pharmacogenomic relationship. Carvedilol and labetalol are mixed alpha and beta blockers; their pharmacodynamic variability profiles at the beta-1 receptor locus are less well characterized than metoprolol's.

Correct Answer

A — Both drugs block the same cardiac potassium channel responsible for repolarization, producing additive QT prolongation that may push the corrected QT interval above the threshold for torsades de pointes

Rationale

QT prolongation is a pharmacodynamic effect caused by blockade of the rapid delayed rectifier potassium current in ventricular myocytes — the same cardiac channel blocked by sotalol and azithromycin through independent mechanisms. When both drugs are present, their blocking effects at the channel level are additive: the combined prolongation of ventricular repolarization is greater than either drug alone. A corrected QT interval above approximately 500 milliseconds substantially increases the risk of early afterdepolarizations that can trigger torsades de pointes. This is a pharmacodynamic interaction at the effector (the cardiac channel), not a pharmacokinetic interaction. Azithromycin does not meaningfully inhibit sotalol metabolism, and the interaction does not involve adrenergic receptors.

Correct Answer

C — Blockade of cardiac potassium channels delays ventricular repolarization, prolonging the action potential duration and creating a window during which early afterdepolarizations can arise and trigger arrhythmia

Rationale

Ventricular repolarization depends on outward potassium current through cardiac potassium channels. QT-prolonging drugs block these channels, slowing the outward potassium current and prolonging the action potential. On the surface electrocardiogram this appears as a lengthened QT interval. During the prolonged repolarization phase, ventricular myocytes can develop early afterdepolarizations — spontaneous depolarizations that arise before repolarization is complete. If an early afterdepolarization achieves threshold and triggers an action potential, it initiates torsades de pointes, a characteristic polymorphic ventricular tachycardia with rotating QRS morphology. Risk factors that amplify this mechanism include hypokalemia (which further reduces outward potassium current), female sex, bradycardia, and pre-existing congenital long QT syndrome. Sodium-potassium ATPase inhibition is the mechanism of digoxin toxicity, which causes delayed rather than early afterdepolarizations.

Correct Answer

B — Opioids and benzodiazepines suppress brainstem respiratory drive through different receptor mechanisms that converge on the same effector, producing additive to synergistic respiratory depression

Rationale

Opioids activate mu-opioid receptors through Gi signaling, hyperpolarizing respiratory neurons and reducing their firing rate. Benzodiazepines enhance gamma-aminobutyric acid type A receptor-mediated chloride conductance, further inhibiting these neurons through a completely independent mechanism. Both pathways converge on the same brainstem respiratory control centers, and their combined inhibitory input produces respiratory depression that is greater than either drug alone. This is a pharmacodynamic interaction at the effector — the respiratory control network — not a pharmacokinetic one involving drug metabolism. Because the interaction occurs at the neuronal level rather than in plasma, it cannot be predicted or monitored by measuring plasma drug concentrations of either agent. Benzodiazepines do not act at opioid receptors and do not inhibit the hepatic enzymes primarily responsible for opioid metabolism.

Correct Answer

D — Each drug removes one compensatory mechanism for maintaining glomerular filtration rate — prostaglandin-mediated afferent dilation, angiotensin II-mediated efferent constriction, and volume — so together they precipitate acute kidney injury

Rationale

Glomerular filtration rate is maintained under conditions of reduced renal perfusion by three compensatory mechanisms: prostaglandin-mediated vasodilation of the afferent arteriole, angiotensin II-mediated constriction of the efferent arteriole to maintain filtration pressure, and adequate circulating volume. Nonsteroidal anti-inflammatory drugs block prostaglandin synthesis, removing afferent arteriolar dilation. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers block the renin-angiotensin-aldosterone system, eliminating efferent arteriolar constriction. Diuretics reduce circulating volume. Each drug alone is manageable, but together they remove all three mechanisms simultaneously, precipitating a sharp fall in glomerular filtration rate and acute kidney injury — particularly in elderly patients and those with heart failure or chronic kidney disease whose baseline renal perfusion is already reduced.

Correct Answer

A — Tolerance to oxycodone has reduced mu-opioid receptor number and sensitivity; because morphine acts at the same receptor pool, it also encounters a desensitized system and requires higher concentrations to produce equivalent analgesia

Rationale

Cross-tolerance occurs when tolerance developed to one drug reduces the response to another drug acting at the same receptor. Both oxycodone and morphine are full agonists at the mu-opioid receptor. Chronic oxycodone exposure causes receptor desensitization, internalization, and downregulation — the receptor pool available to any mu-opioid agonist is reduced or less responsive. When morphine is given, it encounters this same compromised receptor population and therefore requires substantially higher concentrations to achieve the same analgesic effect as in an opioid-naive patient. This is a pharmacodynamic consequence of shared receptor biology. Recognizing cross-tolerance is essential for perioperative pain management in patients on chronic opioids, as standard opioid doses will consistently under-treat their pain.

Correct Answer

C — Physical dependence — chronic receptor blockade has caused receptor upregulation, so abrupt withdrawal produces a withdrawal syndrome requiring gradual tapering

Rationale

Physical dependence is a physiological state in which the body has adapted to continuous drug presence, and a withdrawal syndrome occurs on abrupt discontinuation. It is a predictable consequence of chronic drug exposure and does not imply addiction. Chronic beta-blocker use produces receptor upregulation as a compensatory response to reduced signaling; abrupt discontinuation exposes these upregulated receptors to catecholamines, causing rebound tachycardia, hypertension, and potentially angina in patients with coronary artery disease. Gradual tapering over one to two weeks allows receptor density to normalize and prevents this withdrawal syndrome. Addiction involves compulsive drug-seeking behavior driven by neurobiological reward pathway changes — entirely different from the receptor adaptation seen with metoprolol. Tolerance describes a reduced drug effect requiring dose escalation to maintain the same response — a phenomenon that may also develop with beta-blockers over time but is distinct from the withdrawal syndrome seen here. Tachyphylaxis develops within hours of drug exposure, not after years of stable therapy.

Correct Answer

B — A variant allele in the vitamin K epoxide reductase complex 1 gene — more common in East Asian populations — reduces target enzyme expression, making the enzyme more sensitive to warfarin inhibition at a given plasma concentration

Rationale

Warfarin inhibits vitamin K epoxide reductase complex 1. A promoter polymorphism in this gene reduces enzyme expression: patients carrying the variant allele produce less target enzyme. Because warfarin's anticoagulant effect depends on how much enzyme it inhibits, patients with less enzyme achieve the same degree of clotting factor suppression at a lower warfarin dose — they are pharmacodynamically more sensitive to warfarin. This variant allele is more common in East Asian populations than in European populations, explaining a significant portion of the inter-ethnic difference in warfarin dose requirements. This is a pharmacodynamic interaction at the level of the drug's target, not a pharmacokinetic difference in drug metabolism or protein binding. Dietary vitamin K can affect warfarin response, but it does not explain a systematic population-level pharmacodynamic difference.

Correct Answer

D — In Dravet syndrome, inhibitory interneurons are already compromised by the SCN1A loss-of-function mutation; carbamazepine further suppresses their sodium channel activity, worsening inhibitory tone and increasing seizures

Rationale

The SCN1A gene encodes a sodium channel subtype preferentially expressed in inhibitory interneurons. Loss-of-function mutations reduce these interneurons' ability to fire, resulting in reduced inhibitory tone throughout the brain and severe seizure susceptibility. In most epilepsies, sodium channel-blocking drugs reduce neuronal excitability by suppressing action potentials in hyperactive excitatory neurons. In Dravet syndrome, the same mechanism operates on the already-compromised inhibitory interneurons, further impairing their function. The net result is a paradoxical worsening of seizures rather than improvement. This is a genetically determined pharmacodynamic response: the drug's mechanism, which is beneficial in most patients, becomes harmful when applied to a pathologically altered neural circuit. Sodium channel-blocking antiepileptics — including carbamazepine, phenytoin, and lamotrigine — are contraindicated in Dravet syndrome. Preferred agents include valproate, clobazam, fenfluramine, and cannabidiol.

Correct Answer

C — Both methadone and azithromycin block cardiac potassium channels responsible for repolarization; their combined effect has pushed the corrected QT interval to a level associated with torsades de pointes risk

Rationale

Methadone is notable among opioids for its significant cardiac potassium channel-blocking activity, which independently prolongs the QT interval even at therapeutic doses. Azithromycin is a macrolide antibiotic that also blocks cardiac potassium channels and prolongs the QT interval. When both drugs are given together, their effects at the same channel are additive, and the corrected QT interval rises above the threshold of approximately 500 milliseconds that substantially increases torsades de pointes risk. This is a pharmacodynamic interaction — the interaction occurs at the cardiac channel regardless of what happens to plasma drug concentrations of either agent. The combination of methadone with any QT-prolonging drug warrants electrocardiographic monitoring before and after the addition, and avoidance when alternatives exist.

Correct Answer

A — Gabapentin added to opioid-mediated brainstem respiratory suppression through an independent pharmacodynamic mechanism, producing respiratory depression greater than the opioid alone

Rationale

Gabapentin reduces excitatory neurotransmitter release through calcium channel modulation in the brainstem and spinal cord. When added to an opioid that already suppresses brainstem respiratory drive through mu-opioid receptor activation, gabapentin contributes additional inhibitory input to the same respiratory control centers through a distinct mechanism. The combined pharmacodynamic effect produces respiratory depression beyond what either drug would cause alone. This interaction cannot be predicted or prevented by measuring plasma concentrations of either drug — the interaction occurs at the neural effector level. Population-level data show that opioid-gabapentinoid combinations are associated with meaningfully higher overdose mortality than opioids alone. Gabapentin does not inhibit opioid-metabolizing enzymes, does not act at opioid receptors, and does not affect renal drug clearance.

Correct Answer

D — Cross-tolerance between opioids at the mu-opioid receptor is incomplete, so the patient is relatively more sensitive to a new opioid than the equianalgesic dose would predict, allowing effective analgesia at a lower dose

Rationale

While both morphine and hydromorphone are full agonists at the mu-opioid receptor, the receptor adaptations that develop during chronic morphine exposure — desensitization, internalization, and downregulation — do not transfer completely to the new opioid. This incomplete cross-tolerance means the patient's receptor system, though adapted to morphine, responds somewhat better to hydromorphone than a simple equianalgesic dose calculation would suggest. Clinicians exploit this by reducing the calculated equianalgesic dose by 25 to 50 percent when rotating, then titrating upward based on analgesic response. The result is often improved analgesia at a lower relative dose with fewer side effects. Hydromorphone acts at the same mu-opioid receptor as morphine and does not bypass the receptor system; it is a metabolic difference in opioid handling, not receptor selectivity, that distinguishes these drugs pharmacokinetically.

Correct Answer

B — The SCN1A mutation impairs sodium channel function in inhibitory interneurons; carbamazepine further suppresses these already-compromised channels, reducing inhibitory tone and worsening seizures

Rationale

This presentation — fever-triggered prolonged seizures beginning in infancy with subsequent seizure worsening on carbamazepine and an SCN1A loss-of-function mutation — is characteristic of Dravet syndrome. The SCN1A gene encodes a sodium channel subtype expressed predominantly in inhibitory interneurons. The loss-of-function mutation reduces inhibitory interneuron firing, allowing seizures to emerge with minimal provocation. Carbamazepine, by further blocking sodium channels in these same interneurons, worsens the inhibitory deficit and paradoxically increases seizure frequency and severity. This is a genetically determined adverse pharmacodynamic response: the mechanism that makes sodium channel blockers beneficial in most epilepsies causes harm when the pathological lesion is in the inhibitory interneurons these drugs suppress. Sodium channel-blocking antiepileptics are contraindicated in Dravet syndrome; valproate, clobazam, fenfluramine, and cannabidiol are preferred.